APPOS - Detroit


November 5th - November 6th, 2021

Agenda

Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.

Friday, November 5, 2021

8:00am

Horizon CME App Overview

8:10am

Welcome, Introductions, & CE Housekeeping

8:15am

(01) Acute Lymphocytic Leukemia: Management Strategies for Young Adult Patients
» Lydia Benitez, PharmD, BCOP

9:15am

Exhibit Break

9:35am

(02) HR+/HER2- Metastatic Breast Cancer: An Update for APPs
» Allison Butts, PharmD, BCOP - University of Kentucky Healthcare

10:35am

 Exhibit Break 

10:55am

(03) Urgent Oncology: Strategies for Outpatient Management
» Marilyn Douglas, MSN, FNP-BC, OCN - City of Hope 

11:55am

Exhibit Break

12:10pm

Non-CME/CE Presentation Sponsored by Taiho Oncology: LONSURF® (trifluridine and tipiracil) tablets: Oral chemotherapy for previously treated metastatic colorectal, gastric and gastroesophageal (GEJ) cancers
»  K atherine Alexander, MS, AGACNP-BC, RN, BBAs

1:00pm

(04) Immunology: Back to Basics 
» Gianni Bruno Scappaticci, PharmD, BCOP - Michigan Medicine

2:00pm

(05) Myelodysplastic Syndrome (MDS): An Update for Advanced Practice Providers 
» Muhammed Usman, MD - Bronson Health

3:00pm Adjourn

Saturday, November 6, 2021

8:00am

Horizon CME App Overview

8:10am

Welcome, Introductions, & CE Housekeeping

8:15am

(06) The Evolution of Drug Therapy in Oncology: Recent  Advances in Cancer Drug Therapy
» Rowena (Moe) Schwartz, PharmD, BCOP, FHOPA - University of Cincinnati Barrett Cancer Center

9:15am

Exhibit Break

9:35am

(07) Unique Toxicities of Specific Oncology Drug
» Rowena (Moe) Schwartz, PharmD, BCOP, FHOPA - University of Cincinnati Barrett Cancer Center

10:35am

Exhibit Break

10:55am 

(08) Infectious Disease and Oncology Case-Based Approach
» Steven Stone, PA-C - Western Michigan Cancer Center

11:55am

Exhibit Break

12:10pm

Non-CE Symposium Presentation Sponsored by MorphoSys/Incyte Monjuvi: MONJUVI (Tafasitamab- cxix) For Use As Second-Line Therapy In Adult Patients With R/R DLBCL, In Combination With Lenalidomide
» Kristi Orbaugh, RN, MSN RNP, AOCN | Community Hospital Oncology
 

1:00pm

(09) Cancer-Related Thrombosis: The Great Debate on the Best Way to Anticoagulate
» Victoria Nachar, PharmD, BCOP - University of Michigan
» Allison Schepers, PharmD, BCOP - University of Michigan

2:15pm

(10) Improving Outcomes in BRAF-Mutant mCRC Through Screening and Targeted Therapy
» M. Najeeb Al Hallak, MD, MS -Karmanos Cancer Institute

3:15pm

Closing Comments

 

$75.00